Results 151 to 160 of about 4,094,798 (294)
MT1-MMP inhibition rejuvenates ageing brain and rescues cognitive deficits in obesity. [PDF]
Asthana P+22 more
europepmc +1 more source
Bony Sequestrum, Believed to be the Annulus Tympanicus, Removed from the External Meatus of an Infant, Aged 2 Years 9 Months [PDF]
H. Lawson Whale
openalex +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira+14 more
wiley +1 more source
Exploring quality improvement processes for psychotropic medication use in Australian residential aged care homes: a qualitative study. [PDF]
Shrestha S+11 more
europepmc +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian+10 more
wiley +1 more source
Better growth outcomes in GH-deficient children treated younger than 2 years of age. [PDF]
Rohrer TR+7 more
europepmc +1 more source
Age Distribution in Milk-Borne Outbreaks of Scarlet Fever and Diphtheria
Edward S. Godfrey
openalex +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source